top | item 39653029

(no title)

tester89 | 2 years ago

It’s not as bad, true. But you have to consider the amount of money wasted in the phase 3 trial, resources which could’ve been put to better uses.

discuss

order

skwirl|2 years ago

I don't think there were many better hopes out there for ALS. That's why they approved the drug despite weak data supporting it. This outcome is devastating for people with ALS and their families.

Karunamon|2 years ago

As someone with ALS, This drug was prescribed for me by my doctor as equivalent to other ALS medications, namely that they barely slow the progression of the disease. We are talking three to six months of life extension.

You are overselling the effects of this drug harder than the manufacturer did.

chowells|2 years ago

Drugs shouldn't be approved on hope. They should be approved on evidence. And there was never any evidence for this one. Just letting it inspire hope was hurting its victims.

rafaelero|2 years ago

You don't have to worry about that, because companies are the ones financing it and if they don't believe the drug have a good chance of working they won't fund it.